)
)
Barinthus Biotherapeutics plc Investor Relations Material
Latest events
Status Update
Barinthus Biotherapeutics plc
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Barinthus Biotherapeutics plc
Access all reports
Barinthus Biotherapeutics plc is a biotechnology company focused on the development of novel immunotherapies for infectious diseases and cancer. The company specializes in T-cell activating therapeutics and next-generation vaccine platforms designed to enhance immune response. The company is headquartered in London, United Kingdom, and its shares are listed on the NASDAQ.
Key slides for Barinthus Biotherapeutics plc
Corporate Presentation
Barinthus Biotherapeutics plc
Corporate Presentation
Barinthus Biotherapeutics plc
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
BRNS
Country
🇺🇸 United States